425: Strive CFO Reposts Merger Update with Semler Scientific

Strive's CFO reposted a communication on X.com regarding the proposed business combination with Semler Scientific, highlighting forward-looking statements and regulatory filing details.

Summary

• Ben Pham, Chief Financial Officer of Strive, Inc., reposted a communication on X.com on October 2, 2025, concerning the proposed business combination with Semler Scientific, Inc.
• The communication includes a cautionary statement regarding forward-looking statements, emphasizing inherent risks and uncertainties associated with the transaction.
• It outlines various risks, including the possibility of the merger not closing, integration difficulties, and potential dilution from Strive's stock issuance.
• Strive intends to file a Registration Statement on Form S-4 with the SEC, which will include an Information Statement/Proxy Statement/Prospectus for Semler Scientific stockholders.
• Investors and stockholders are strongly urged to read the Registration Statement and other relevant SEC filings when they become available for important information.
• The filing identifies Strive, Semler Scientific, and certain directors, executive officers, and employees as potential participants in the solicitation of proxies for the proposed transaction.
• It clarifies that this communication does not constitute an offer to sell or a solicitation of an offer to buy any securities.

Sentiment

Score: 5

Explanation: The filing is neutral in tone, primarily a legal disclosure about a proposed merger and its associated risks, without presenting specific positive or negative financial results or operational updates.

Positives

• The proposed transaction aims to achieve strategic and financial benefits for the combined company, including anticipated cost savings and strategic gains.

Negatives

• The proposed transaction carries risks that it may not close as expected or at all due to unmet conditions.
• Integration of the two companies may be more difficult, time-consuming, or costly than anticipated.
• The transaction could be more expensive or take longer to complete than initially projected.
• Management's attention may be diverted from ongoing business operations and opportunities during the merger process.
• Strive's issuance of additional shares of its Class A common stock in connection with the transaction will cause dilution for existing shareholders.
• There is a possibility of adverse reactions from Strive's or Semler Scientific's customers or changes to business or employee relationships.
• Changes in Strive's or Semler Scientific's share price may occur before the closing of the transaction.

Risks

• The occurrence of any event, change, or circumstance that could lead to the termination of the merger agreement.
• The possibility that conditions to closing the proposed transaction are not received or satisfied on a timely basis or at all.
• The outcome of any legal proceedings that may be instituted against Strive, Semler Scientific, or the combined company.
• Anticipated benefits of the proposed transaction, including cost savings and strategic gains, may not be realized as expected or at all.
• Risks associated with changes in, or problems arising from, the implementation of Bitcoin treasury strategies and other digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, and laws and regulations and their enforcement could negatively impact the combined company.
• The integration of the two companies may prove more difficult, time-consuming, or costly than expected.
• The proposed transaction may be more expensive or take longer to complete than anticipated due to unexpected factors or events.
• Diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock.
• Potential adverse reactions from Strive's or Semler Scientific's customers or changes to business or employee relationships.
• Changes in Strive's or Semler Scientific's share price before closing.
• Other unknown or unpredictable factors could harm Strive, Semler Scientific, or the combined company's results.

Future Outlook

The outlook and expectations of Strive and Semler Scientific are focused on the proposed transaction, including its strategic and financial benefits, the expected impact on the combined company's future financial performance, the timing of the closing, and the ability to successfully integrate the businesses.

Management Comments

• Ben Pham, Chief Financial Officer of Strive, Inc., reposted the communication on X.com on October 2, 2025, in connection with the proposed business combination.

Industry Context

This communication relates to a proposed business combination, a common strategic move in various industries for growth or consolidation. The mention of 'Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets' suggests that one or both companies may be operating in or expanding into the digital asset space, reflecting a broader trend of corporate adoption of cryptocurrencies.

Stakeholder Impact

• Shareholders: Potential dilution from Strive's issuance of additional Class A common stock; Semler Scientific stockholders will vote on the proposed transaction.
• Customers: Potential for adverse reactions or changes to business relationships.
• Employees: Potential for changes to employee relationships.

Next Steps

• Strive intends to file a Registration Statement on Form S-4 with the SEC to register the Class A common stock to be issued.
• The Registration Statement will include an Information Statement of Strive, a proxy statement of Semler Scientific, and a prospectus of Strive.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to the stockholders of Semler Scientific to seek their approval of the proposed transaction.
• Investors and stockholders of Semler Scientific are urged to read the Registration Statement and Information Statement/Proxy Statement/Prospectus when they become available, along with any other relevant documents filed with the SEC.

Key Dates

Keywords

Strive, Semler Scientific, Merger, Business Combination, SEC Filing, Form 425, Forward-Looking Statements, Bitcoin, Digital Assets, Corporate Governance, Financial Reporting